Abstract
Melanie Ehrlich, PhD, is Professor in the Human Genetics Program, the Tulane Cancer Center, and the Program in Bioinformatics and Genomics at Tulane University Health Sciences Center, New Orleans, LA, USA. She obtained her PhD in molecular biology in 1971 from the State University of New York at Stony Brook and completed postdoctoral research at Albert Einstein College of Medicine in 1972. She has been working on various aspects of epigenetics, starting with DNA methylation, since 1972. Her laboratory is currently studying the interrelationships of tissue-specific changes in DNA methylation and hydroxymethylation with alterations in chromatin structure and gene expression in differentiation and disease.
Financial & competing interests disclosure
M Ehrlich has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.